Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 6—June 2011


Cefepime-Resistant Pseudomonas aeruginosa

Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, and Ebbing LautenbachComments to Author 
Author affiliations: Author affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table 4

Multivariable model of cefepime-resistant Pseudomonas aeruginosa infection and death (blood isolates only), Philadelphia, PA, USA, 2001–2006*

Variable Adjusted OR (95% CI) p value
Cefepimeiresistant organism 15.55 (3.10–77.89) 0.001
Patient in ICU at time of culture 3.22 (1.50–6.91) 0.003
APR-DRG 4.48 (1.60–12.60) 0.004
Patient transfer from outside hospital 1.26 (0.56–2.86) 0.57
Length of hospital stay before culture 1.01 (0.99–1.04) 0.80

*OR, odds ratio; CI, confidence interval; ICU, intensive care unit; APR-DRG, all-patient refined-diagnosis–related group.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO